| Dr Margaret A Bahder, MD | |
|
41 Glendale Pl Ste 9, Gilford, NH 03249-7644 | |
| (603) 293-0026 | |
| (603) 293-4036 |
| Full Name | Dr Margaret A Bahder |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 41 Glendale Pl Ste 9, Gilford, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396845319 | NPI | - | NPPES |
| 30200977 | Medicaid | NH | |
| 0109749Y0NH01 | Other | NH | BC/BS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 10773 (New Hampshire) | Primary |
| Entity Name | Bahder Behavioral Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366541062 PECOS PAC ID: 3375549330 Enrollment ID: O20061013000481 |
News Archive
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled "Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials" was presented by Dr. Jacques Genest.
Researchers at the University of Colorado College of Nursing at the Anschutz Medical Campus found that a unique set of factors of the emergency department (ED) makes standard Clinical Decision Support (CDS) systems not as effective in helping to reduce antibiotic overprescribing in that environment.
From a sample of over 300 college newspapers, findings revealed that almost one-quarter of advertisements offered payment in excess of $10,000, a violation of guidelines issued by the American Society for Reproductive Medicine (ASRM).
› Verified 5 days ago
| Entity Name | Savida Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285388546 PECOS PAC ID: 4082809967 Enrollment ID: O20230823000305 |
News Archive
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled "Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials" was presented by Dr. Jacques Genest.
Researchers at the University of Colorado College of Nursing at the Anschutz Medical Campus found that a unique set of factors of the emergency department (ED) makes standard Clinical Decision Support (CDS) systems not as effective in helping to reduce antibiotic overprescribing in that environment.
From a sample of over 300 college newspapers, findings revealed that almost one-quarter of advertisements offered payment in excess of $10,000, a violation of guidelines issued by the American Society for Reproductive Medicine (ASRM).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Margaret A Bahder, MD 41 Glendale Pl Ste 9, Gilford, NH 03249-7644 Ph: (603) 293-0026 | Dr Margaret A Bahder, MD 41 Glendale Pl Ste 9, Gilford, NH 03249-7644 Ph: (603) 293-0026 |
News Archive
Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that its Data Monitoring Committee has reviewed the initial safety data from all three patients in the first cohort and has recommended dose escalation to the second cohort.
Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled "Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials" was presented by Dr. Jacques Genest.
Researchers at the University of Colorado College of Nursing at the Anschutz Medical Campus found that a unique set of factors of the emergency department (ED) makes standard Clinical Decision Support (CDS) systems not as effective in helping to reduce antibiotic overprescribing in that environment.
From a sample of over 300 college newspapers, findings revealed that almost one-quarter of advertisements offered payment in excess of $10,000, a violation of guidelines issued by the American Society for Reproductive Medicine (ASRM).
› Verified 5 days ago
Nicolette Gebhardt, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Maple St, Gilford, NH 03249 Phone: 603-737-6755 | |
Michael Alan Evans, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 25 Country Club Rd, Gilford, NH 03249 Phone: 603-528-2573 Fax: 603-528-2558 | |
Dr. Christopher Joseph Martino, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14 Maple St, Ste 400, Gilford, NH 03249 Phone: 603-524-0700 Fax: 603-528-3521 |